VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy

VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy

Αποθηκεύτηκε σε:

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Evgeny Arons, Tara Suntum, Maryalice Stetler‐Stevenson, Robert J. Kreitman
Μορφή:	Artigo
Γλώσσα:	Αγγλικά
Έκδοση:	2009
Διαθέσιμο Online:	https://doi.org/10.1182/blood-2009-01-201731 https://ashpublications.org/blood/article-pdf/114/21/4687/1319390/zh804709004687.pdf
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια

VH4-34(+) hairy cell leukemia, a new variant with poor prognosis despite standard therapy
από: Arons, Evgeny, κ.ά.
Έκδοση: (2009)

PRAME expression in Hairy Cell Leukemia
από: Arons, Evgeny, κ.ά.
Έκδοση: (2008)

Evidence of canonical somatic hypermutation in hairy cell leukemia
από: Arons, Evgeny, κ.ά.
Έκδοση: (2011)

Response of hairy cell leukemia to bendamustine
από: KREITMAN, ROBERT J., κ.ά.
Έκδοση: (2011)

Molecular variant of hairy cell leukemia with poor prognosis
από: ARONS, EVGENY, κ.ά.
Έκδοση: (2011)

Both variant and IGHV4-34–expressing hairy cell leukemia lack the BRAF V600E mutation
από: Xi, Liqiang, κ.ά.
Έκδοση: (2012)

Both variant and IGHV4-34–expressing hairy cell leukemia lack the BRAF V600E mutation
από: Liqiang Xi, κ.ά.
Έκδοση: (2011)

Bendamustine and Rituximab in Relapsed and Refractory Hairy Cell Leukemia
από: Burotto, Mauricio, κ.ά.
Έκδοση: (2013)

Bendamustine and Rituximab in Relapsed and Refractory Hairy Cell Leukemia
από: Mauricio Burotto, κ.ά.
Έκδοση: (2013)

Recombinant immunotoxins and other therapies for relapsed/refractory hairy cell leukemia
από: KREITMAN, ROBERT J., κ.ά.
Έκδοση: (2011)

Cladribine with immediate rituximab for the treatment of patients with variant hairy cell leukemia
από: Kreitman, Robert J., κ.ά.
Έκδοση: (2013)

Cladribine with Immediate Rituximab for the Treatment of Patients with Variant Hairy Cell Leukemia
από: Robert J. Kreitman, κ.ά.
Έκδοση: (2013)

Update on Hairy Cell Leukemia
από: Kreitman, Robert J., κ.ά.
Έκδοση: (2018)

Distinguishing hairy cell leukemia variant from hairy cell leukemia: Development and validation of diagnostic criteria
από: Haipeng Shao, κ.ά.
Έκδοση: (2013)

Distinguishing Hairy Cell Leukemia Variant from Hairy Cell Leukemia: Development and Validation of Diagnostic Criteria
από: Shao, Haipeng, κ.ά.
Έκδοση: (2013)

Differential Expression of CD43, CD81, and CD200 in Classic Versus Variant Hairy Cell Leukemia
από: Salem, Dalia A., κ.ά.
Έκδοση: (2019)

Diagnosis and treatment of hairy cell leukemia as the COVID-19 pandemic continues
από: Kreitman, Robert J., κ.ά.
Έκδοση: (2022)

Soluble CD22 as a tumor marker for hairy cell leukemia
από: Matsushita, Kakushi, κ.ά.
Έκδοση: (2008)

Characteristic CD103 and CD123 Expression Pattern Defines Hairy Cell Leukemia
από: Girish Venkataraman, κ.ά.
Έκδοση: (2011)

Usefulness of Dual Immunohistochemistry Staining in Detection of Hairy Cell Leukemia in Bone Marrow
από: Gupta, Gaurav K, κ.ά.
Έκδοση: (2020)

Variables in the Quantification of CD4 in Normals and Hairy Cell Leukemia Patients
από: Wang, Lili, κ.ά.
Έκδοση: (2011)

Expression of the muscle-associated gene MYF6 in hairy cell leukemia
από: Arons, Evgeny, κ.ά.
Έκδοση: (2020)

High prevalence of MAP2K1 mutations in variant and IGHV4-34–expressing hairy-cell leukemias
από: Joshua J. Waterfall, κ.ά.
Έκδοση: (2013)

High prevalence of MAP2K1 mutations in variant and IGHV4-34 expressing hairy-cell leukemia
από: Waterfall, Joshua J., κ.ά.
Έκδοση: (2013)

Efficacy of the Anti-CD22 Recombinant Immunotoxin BL22 in Chemotherapy-Resistant Hairy-Cell Leukemia
από: Robert J. Kreitman, κ.ά.
Έκδοση: (2001)

Characteristic CD103 and CD123 Expression Pattern Defines Hairy Cell Leukemia: Usefulness of CD123 and CD103 in the Diagnosis of Mature B-Cell Lymphoproliferative Disorders
από: Venkataraman, Girish, κ.ά.
Έκδοση: (2011)

Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell Leukemia
από: Chihara, Dai, κ.ά.
Έκδοση: (2020)

Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell Leukemia
από: Dai Chihara, κ.ά.
Έκδοση: (2020)

Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variant
από: Chihara, Dai, κ.ά.
Έκδοση: (2021)

Phase II Trial of Recombinant Immunotoxin RFB4(dsFv)-PE38 (BL22) in Patients With Hairy Cell Leukemia
από: Robert J. Kreitman, κ.ά.
Έκδοση: (2009)

FCRL1 on chronic lymphocytic leukemia, hairy cell leukemia, and B-cell non-Hodgkin lymphoma as a target of immunotoxins
από: Du, Xing, κ.ά.
Έκδοση: (2008)

Phase II Trial of Recombinant Immunotoxin RFB4(dsFv)-PE38 (BL22) in Patients With Hairy Cell Leukemia
από: Kreitman, Robert J., κ.ά.
Έκδοση: (2009)

Phase I Trial of Anti-CD22 Recombinant Immunotoxin Moxetumomab Pasudotox (CAT-8015 or HA22) in Patients With Hairy Cell Leukemia
από: Kreitman, Robert J., κ.ά.
Έκδοση: (2012)

Phase I Trial of Anti-CD22 Recombinant Immunotoxin Moxetumomab Pasudotox (CAT-8015 or HA22) in Patients With Hairy Cell Leukemia
από: Robert J. Kreitman, κ.ά.
Έκδοση: (2012)

Case Study Interpretation—Portland: Case 1. Hairy cell leukemia with CLL-like monoclonal B lymphocytosis
από: Tembhare, Prashant, κ.ά.
Έκδοση: (2012)

Minimal residual hairy cell leukemia eradication with moxetumomab pasudotox: phase 1 results and long-term follow-up
από: Kreitman, Robert J., κ.ά.
Έκδοση: (2018)

Minimal residual hairy cell leukemia eradication with moxetumomab pasudotox: phase 1 results and long-term follow-up
από: Robert J. Kreitman, κ.ά.
Έκδοση: (2018)

Hairy cell leukemia: present and future directions
από: Kreitman, Robert J.
Έκδοση: (2019)

Hairy cell leukemia: present and future directions
από: Robert J. Kreitman
Έκδοση: (2019)

Development of Recombinant Immunotoxins for Hairy Cell Leukemia
από: Kreitman, Robert J., κ.ά.
Έκδοση: (2020)